← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2000Last known activity
May 1, 2012
Defunct as of Jan 1, 2012
Timeline
1980s
- Jan 1, 1988
Genta— Founded
2010s
- Jan 1, 2012
Genta— Defunct
Drugs by trial phase (21 distinct, 31 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Melanoma
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Plasmacytoma
- Prostatic Neoplasms
- Renal Insufficiency
- Stomach Neoplasms
Recent trials (36)
- NCT01609127Lead sponsorPhase 2May 1, 2012
- NCT01573468Lead sponsorPhase 2Apr 1, 2012
- NCT01348009Lead sponsorPhase 1/Phase 2May 1, 2011
- NCT01337310Lead sponsorPhase 1Apr 1, 2011
- NCT01315431Lead sponsorPhase 1Mar 1, 2011
- NCT01296243Lead sponsorPhase 2Feb 1, 2011
- NCT01200342CollaboratorPhase 2Dec 1, 2010
- NCT01221870Lead sponsorPhase 2Nov 1, 2010
- NCT01215877Lead sponsorPhase 2Sep 1, 2010
- NCT01170975Lead sponsorPhase 1Jun 1, 2010
- NCT01095120Lead sponsorPhase 2Mar 1, 2010
- NCT01092585Lead sponsorPhase 2Feb 1, 2010
- NCT01064713CollaboratorPhase 2Feb 1, 2010
- NCT00736450CollaboratorN/AJul 1, 2008
- NCT00836173CollaboratorPhase 2Jul 1, 2008
Details
- Founded
- Berkeley, NJ, US Jan 1, 1988
- Last known activity
- May 1, 2012